SCHEMBL25378159

SCHEMBL25378159

C=Cc1ncc(-c2nccnc2Nc2ccc(C(F)(F)F)cc2)cn1

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 6/20 0.43
▸ EPHX2 P34913 13/20 0.41
▸ EGFR P00533 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25374304 0.85 TRPV1 (0.42) TRPV1EPHX2EGFR
SCHEMBL30482578 0.85 TRPV1 (0.42) TRPV1EPHX2EGFR
SCHEMBL30482518 0.83 TRPV1 (0.46) TRPV1EPHX2EGFR
SCHEMBL30482543 0.83 EPHX2 (0.47) TRPV1EPHX2
SCHEMBL25377909 0.83 TRPV1 (0.46) TRPV1EPHX2EGFR
SCHEMBL25377441 0.83 EPHX2 (0.47) TRPV1EPHX2
SCHEMBL25376142 0.82 EPHX2 (0.45) TRPV1EPHX2
SCHEMBL30482483 0.80 TGM2 (0.52) TRPV1EGFR
SCHEMBL25376358 0.80 TGM2 (0.52) TRPV1EGFR
SCHEMBL25377798 0.80 TRPV1 (0.46) TRPV1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146512-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
WO-2023146512-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback